MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer-Reference-Cited by-同舟云学术

MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer

Published:2022-02-01 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Hagiwara Masayuki¹^ORCID,Fushimi Atsushi¹^ORCID,Bhattacharya Atrayee¹^ORCID,Yamashita Nami¹^ORCID,Morimoto Yoshihiro¹^ORCID,Oya Mototsugu²,Withers Henry G.³^ORCID,Hu Qiang³^ORCID,Liu Tao³^ORCID,Liu Song³,Wong Kwok K.⁴^ORCID,Long Mark D.³^ORCID,Kufe Donald¹^ORCID

Affiliation:

1. Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA

2. Department of Urology, Keio University School of Medicine, Tokyo, Japan

3. Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

4. Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA

Funder

National Cancer Institute of the National Institutes of Health

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link